Drug Shortage Report for KADIAN
| Report ID | 129190 |
| Drug Identification Number | 02242163 |
| Brand name | KADIAN |
| Common or Proper name | KADIAN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | MORPHINE SULFATE |
| Strength(s) | 10MG |
| Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100BT |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-12-16 |
| Actual start date | 2020-12-16 |
| Estimated end date | 2021-01-26 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-01-12 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.